{"id":"NCT04147650","sponsor":"Aurinia Pharmaceuticals Inc.","briefTitle":"Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome","officialTitle":"A Randomized, Double-Masked, Vehicle-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution (VOS) in Subjects With Dry Eye Syndrome (DES)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2019-10-14","primaryCompletion":"2020-09-17","completion":"2020-10-08","firstPosted":"2019-11-01","resultsPosted":"2021-12-10","lastUpdate":"2021-12-10"},"enrollment":508,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye Syndrome","Keratoconjunctivitis Sicca"],"interventions":[{"type":"DRUG","name":"0.05% Voclosporin Ophthalmic Solution (VOS)","otherNames":[]},{"type":"DRUG","name":"0.10% VOS","otherNames":[]},{"type":"DRUG","name":"0.20% VOS","otherNames":[]},{"type":"DRUG","name":"Vehicle Ophthalmic Solution","otherNames":[]}],"arms":[{"label":"0.05% Voclosporin Ophthalmic Solution (VOS)","type":"EXPERIMENTAL"},{"label":"0.10% VOS","type":"EXPERIMENTAL"},{"label":"0.20% VOS","type":"EXPERIMENTAL"},{"label":"Vehicle Ophthalmic Solution","type":"PLACEBO_COMPARATOR"}],"summary":"A Multi-Center, Phase 2/3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Voclosporin Ophthalmic Solution (0.05%, 0.10%, 0.20%) Compared to Vehicle in Subjects with Dry Eye Syndrome.","primaryOutcome":{"measure":"Number of Subjects With a â‰¥10 mm Increase From Baseline in Schirmer Tear Test (STT)","timeFrame":"4 Weeks","effectByArm":[{"arm":"0.05% Voclosporin Ophthalmic Solution (VOS)","deltaMin":12,"sd":null},{"arm":"0.10% VOS","deltaMin":10,"sd":null},{"arm":"0.20% VOS","deltaMin":13,"sd":null},{"arm":"Vehicle Ophthalmic Solution","deltaMin":6,"sd":null}],"pValues":[{"comp":"OG000","p":"0.1352"},{"comp":"OG001","p":"0.2823"},{"comp":"OG002","p":"0.0889"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":9,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":127},"commonTop":["Instillation site pain"]}}